CMV trivalent vaccine (Vical)

CMV三价疫苗

Report date: 2022/11/27 16:44:57

Base Information

Drug NameCMV trivalent vaccine (Vical)
Drug Alias NameTrivalent immunotherapeutic vaccine (Vical)pDNA CMV trivalent vaccineTrivalent CMV DNA vaccine (Vical)VCL-CT02
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CaliforniaFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California San Francisco
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A